Researchers demonstrate success with new therapy for Covid

New York, Jan 20 : A new therapy developed by researchers is showing success as a way to prevent Covid-19 disease.
The study, published in the Journal of Neuroimmune Pharmacology, showed that mouse models with Covid-19 showed positive results when a small peptide was introduced nasally.
The peptide proved effective in reducing fever, protecting the lungs, improving heart function and reversing cytokine storm — a condition in which an infection triggers the immune system to flood the bloodstream with inflammatory proteins.
“This could be a new approach to prevent SARS-CoV-2 infection and protect Covid-19 patients from breathing problems and cardiac issues,” said researcher Kalipada Pahan, Professor at Rush University in the US.
“Understanding the mechanism is proving important to developing effective therapies for Covid-19,” Pahan added.
Many Covid-19 patients in the ICU suffer from cytokine storm that affects lungs, heart and other organs.